In today’s session Mead Johnson Nutrition CO (MJN) recorded an unusually high (325) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the November, 2016 put, expecting serious MJN decrease. With 325 contracts traded and 7184 open interest for the Nov, 16 contract, it seems this is a quite bearish bet. The option with symbol: MJN161118P00070000 closed last at: $0.95 or 2.1% down. About 1.60 million shares traded hands. Mead Johnson Nutrition CO (NYSE:MJN) has declined 12.89% since April 5, 2016 and is downtrending. It has underperformed by 14.84% the S&P500.
Mead Johnson Nutrition CO (NYSE:MJN) Ratings Coverage
Out of 14 analysts covering Mead Johnson Nutrition Company (NYSE:MJN), 2 rate it a “Buy”, 2 “Sell”, while 10 “Hold”. This means 14% are positive. Mead Johnson Nutrition Company has been the topic of 25 analyst reports since September 16, 2015 according to StockzIntelligence Inc. The stock has “Buy” rating given by Citigroup on Monday, April 18. Deutsche Bank maintained the stock with “Hold” rating in Friday, October 28 report. The firm has “Neutral” rating by Credit Suisse given on Friday, October 23. The firm has “Underperform” rating given on Friday, January 8 by CLSA. The stock of Mead Johnson Nutrition CO (NYSE:MJN) has “Hold” rating given on Thursday, September 17 by Zacks. The company was maintained on Tuesday, January 19 by Credit Suisse. BMO Capital Markets downgraded it to “Market Perform” rating and $89 target price in Thursday, October 15 report. On Wednesday, August 24 the stock rating was initiated by UBS with “Neutral”. The rating was upgraded by Nomura to “Buy” on Wednesday, October 7. The firm earned “Neutral” rating on Tuesday, January 12 by Nomura.
According to Zacks Investment Research, “Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company’s mission is to nourish the world’s children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company’s Enfa family of brands, including EnfamilÂ® infant formula, is the world’s leading brand franchise in pediatric nutrition.”
Insitutional Activity: The institutional sentiment decreased to 0.72 in 2016 Q2. Its down 0.17, from 0.89 in 2016Q1. The ratio is negative, as 44 funds sold all Mead Johnson Nutrition CO shares owned while 220 reduced positions. 37 funds bought stakes while 153 increased positions. They now own 174.74 million shares or 3.52% less from 181.11 million shares in 2016Q1.
Spot Trading Ltd Co accumulated 18,364 shares or 0.03% of the stock. Jennison Associate Lc holds 0.09% or 946,099 shares in its portfolio. American Retail Bank has 0% invested in the company for 17 shares. Tokio Marine Asset Mngmt Ltd owns 51,553 shares or 0.48% of their US portfolio. Pioneer reported 585,323 shares or 0.19% of all its holdings. The Georgia-based Suntrust Banks Incorporated has invested 0% in Mead Johnson Nutrition CO (NYSE:MJN). Ncm Advisers Inc reported 7,046 shares or 1.83% of all its holdings. Bank & Trust Of Montreal Can has 1.12M shares for 0.12% of their US portfolio. Gofen And Glossberg Limited Il accumulated 3,328 shares or 0.01% of the stock. Carroll Financial Inc owns 106 shares or 0% of their US portfolio. Integral Derivatives Limited holds 0.01% of its portfolio in Mead Johnson Nutrition CO (NYSE:MJN) for 2,597 shares. Commercial Bank Of Nova Scotia, a Ontario – Canada-based fund reported 3,726 shares. Macquarie Group Ltd accumulated 0% or 2,200 shares. Smithfield Trust last reported 300 shares in the company. Massachusetts Finance Svcs Ma owns 5.23 million shares or 0.24% of their US portfolio.
Insider Transactions: Since August 4, 2016, the stock had 0 buys, and 3 insider sales for $4.13 million net activity. $4.02M worth of shares were sold by Monteagudo Graciela on Thursday, August 4. $49,195 worth of Mead Johnson Nutrition CO (NYSE:MJN) was sold by Catalano Anna C. CASIANO KIMBERLY A sold $63,724 worth of Mead Johnson Nutrition CO (NYSE:MJN) on Monday, August 15.
Mead Johnson Nutrition Company is a pediatric nutrition company. The company has a market cap of $13.75 billion. The Firm makes, distributes and sells infant formulas, children’s nutrition and other nutritional products. It has a 27.4 P/E ratio. The Firm operates through three divisions: Asia, North America/Europe and Latin America.
MJN Company Profile
Mead Johnson Nutrition Company (Mead Johnson), incorporated on December 17, 2008, is a pediatric nutrition company. The Firm makes, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Firm operates through three divisions: Asia, North America/Europe and Latin America. The Company’s product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. The Company’s product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Firm markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.
Another recent and important Mead Johnson Nutrition CO (NYSE:MJN) news was published by Forbes.com which published an article titled: “Mead Johnson Nutrition Enters Oversold Territory (MJN)” on September 16, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.